Milestone Pharmaceuticals Inc. - Common Shares (MIST) earnings
MIST earnings moved a median of +0.59% by the close. Quarterly and annual MIST reports and results, each read against the price at its own news timestamp. Back to the MIST overview →
24 measured MIST earnings events.
Where these MIST earnings landedvs 22 measured MIST earnings reactions
| Middle 50% of MIST earnings reactions | -2.30% to +4.61% |
|---|---|
| Median reaction (to close) | +0.59% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 MIST earnings events with a measured close landed between -2.30% and +4.61%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Milestone Pharmaceutical For: Jun 30 | SEC filing · Form 10-Q | -0.11% | +1.35% | |
| Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.11% | +1.35% | |
| Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026 | Press release | -0.04% | -4.58% | |
| Form 10-Q Milestone Pharmaceutical For: Mar 31 | SEC filing · Form 10-Q | +12.50% | +7.50% | |
| Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update | Press release | +12.50% | +7.50% | |
| Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 | Press release | +0.00% | +3.14% | |
| Form 10-K Milestone Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | -1.24% | -15.00% | |
| Form 10-Q Milestone Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | -0.53% | -1.03% | |
| Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update | Press release | -0.53% | -1.03% | |
| Form 10-Q Milestone Pharmaceutical For: Jun 30 | SEC filing · Form 10-Q | -0.31% | — | |
| Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update | Press release | +0.00% | — | |
| Form 10-Q Milestone Pharmaceutical For: Mar 31 | SEC filing · Form 10-Q | +6.62% | +5.41% | |
| Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update | Press release | +6.62% | +5.41% | |
| Form 10-K Milestone Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | +8.45% | +1.50% | |
| Form 10-Q Milestone Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.60% | |
| Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update | Press release | +0.00% | -2.60% | |
| Form 10-Q Milestone Pharmaceutical For: Jun 30 | SEC filing · Form 10-Q | -0.35% | -1.40% | |
| Milestone Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Regulatory and Corporate Update | Press release | -0.35% | -1.40% | |
| Form 10-Q Milestone Pharmaceutical For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.59% | |
| Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update | Press release | +0.00% | +0.59% | |
| Form 10-K/A Milestone Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.10% | |
| Form 10-K Milestone Pharmaceutical For: Dec 31 | SEC filing · Form 10-K | +0.72% | +7.59% | |
| Form 10-Q Milestone Pharmaceutical For: Sep 30 | SEC filing · Form 10-Q | +0.35% | -19.03% | |
| Milestone Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Corporate Updates | Press release | +0.35% | -19.03% |
Keep exploring
More MIST: analyst actions → · SEC filings → · MIST overview →